These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 36835039)

  • 1. Gene Therapy of Sphingolipid Metabolic Disorders.
    Shaimardanova AA; Solovyeva VV; Issa SS; Rizvanov AA
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concentrations of an activator protein for sphingolipid hydrolysis in liver and brain samples from patients with lysosomal storage diseases.
    Inui K; Wenger DA
    J Clin Invest; 1983 Nov; 72(5):1622-8. PubMed ID: 6415115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rare Diseases in Glycosphingolipid Metabolism.
    Zhou H; Wu Z; Wang Y; Wu Q; Hu M; Ma S; Zhou M; Sun Y; Yu B; Ye J; Jiang W; Fu Z; Gong Y
    Adv Exp Med Biol; 2022; 1372():189-213. PubMed ID: 35503182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in Sphingolipidoses: CRISPR-Cas9 Editing as an Option for Modelling and Therapy.
    Santos R; Amaral O
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31771289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzymatic abnormalities in diseases of sphingolipid metabolism.
    Brady RO
    Clin Chem; 1967 Jul; 13(7):565-77. PubMed ID: 5006481
    [No Abstract]   [Full Text] [Related]  

  • 6. The sphiningolipidoses: an overview.
    West HH
    Postgrad Med; 1977 Mar; 61(3):90-3, 95. PubMed ID: 402652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysosomal storage diseases.
    Ferreira CR; Gahl WA
    Transl Sci Rare Dis; 2017 May; 2(1-2):1-71. PubMed ID: 29152458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sphingolipidoses in Turkey.
    Ozkara HA; Topçu M
    Brain Dev; 2004 Sep; 26(6):363-6. PubMed ID: 15275696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recent advances in sphingolipidosis research].
    Tamai Y; Kojima H
    Tanpakushitsu Kakusan Koso; 1990 May; 35(7 Suppl):1291-303. PubMed ID: 1972585
    [No Abstract]   [Full Text] [Related]  

  • 10. Basic findings and current developments in sphingolipidoses.
    Pilz H; Heipertz R; Seidel D
    Hum Genet; 1979 Mar; 47(2):113-34. PubMed ID: 108196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysosomal Ceramide Metabolism Disorders: Implications in Parkinson's Disease.
    Paciotti S; Albi E; Parnetti L; Beccari T
    J Clin Med; 2020 Feb; 9(2):. PubMed ID: 32098196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From sheep to mice to cells: tools for the study of the sphingolipidoses.
    Zigdon H; Meshcheriakova A; Futerman AH
    Biochim Biophys Acta; 2014 Aug; 1841(8):1189-99. PubMed ID: 24607565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inherited lipid storage diseases of the central nervous system.
    Percy AK; Shapiro LJ; Kaback MM
    Curr Probl Pediatr; 1979 Sep; 9(11):1-51. PubMed ID: 117977
    [No Abstract]   [Full Text] [Related]  

  • 14. Molecular facets of sphingolipids: mediators of diseases.
    Ozbayraktar FB; Ulgen KO
    Biotechnol J; 2009 Jul; 4(7):1028-41. PubMed ID: 19579220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid storage disease: Part III. Ultrastructural evaluation of cultured fibroblasts in sphingolipidoses.
    Takahashi K; Naito M; Suzuki Y
    Acta Pathol Jpn; 1987 Feb; 37(2):261-72. PubMed ID: 3037847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expanding boundaries of sphingolipid lysosomal storage diseases; insights from Niemann-Pick disease type C.
    Platt FM
    Biochem Soc Trans; 2023 Oct; 51(5):1777-1787. PubMed ID: 37844193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Saul R. Korey Lecture. Molecular genetics of Tay-Sachs and related disorders: a personal account.
    Suzuki K
    J Neuropathol Exp Neurol; 1994 Jul; 53(4):344-50. PubMed ID: 8021707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances and novel treatments for sphingolipidoses.
    Arenz C
    Future Med Chem; 2017 Sep; 9(14):1687-1700. PubMed ID: 28857617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The biochemistry of sphingolipid storage diseases.
    Sandhoff K
    Angew Chem Int Ed Engl; 1977 May; 16(5):273-85. PubMed ID: 406814
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma and dried blood spot lysosphingolipids for the diagnosis of different sphingolipidoses: a comparative study.
    Polo G; Burlina AP; Ranieri E; Colucci F; Rubert L; Pascarella A; Duro G; Tummolo A; Padoan A; Plebani M; Burlina AB
    Clin Chem Lab Med; 2019 Nov; 57(12):1863-1874. PubMed ID: 31091195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.